1/9

ROBOTECH
Robot-Assisted Spinal Surgery

APO Group 4
Saurav, Anish, Akanksha, Soumyajit, Yashi, Vishal
 2/9

Recommendations

Financial Crisis,
there is a cash Bearing the
High-Risk crunch expense of
Investment - Should focus on Too much Kinetics
everywhere,
The market is core dependency on Software
and diverting
uncertain and is competencies outsourcing project for $5
resources into
at its nascent rather than leads to Million plus 10%
complex spinal
stage venturing at vulnerability to of the sales
surgery can
this position. its suppliers price of every
jeopardize
company machine sold
stability for over 5 years
 3/9

Overview of Last 3
Years

1st Year 2nd Year 3rd Year

Sales saw initial success 30% deposit with the Expected sales of 110
but huge demand order creating discontent units reached
resulted in long delays, among customers RoboTech had achieved
training centers were at initial success but faced
capacity with a months- significant challenges
long waiting list requiring strategic
Reimbursement of adaptation.
$33,522 and $35,165
where the expectation
was $40,000 to $60,000
 Future Roadmap 2017 4/9

Expand Sales & Reduce Cost &

Service Prices

Increase the sales force and Negotiate with suppliers,

open service centers to explore cost-saving
address customer demands measures, and consider
and maintain market share. lowering prices to remain
competitive.

Customer relationship Robotech Focus on core

Management technology:

Strengthen relationships Invest in R&D to upgrade the

with existing customers existing spinal system and
through excellent service potentially develop other
and support to enhance units of surgery.
loyalty and retention.
 5/9
Future Strategic Options
Investing in Diversification
Expanding R&D for a into Spinal
sales and combined-use Partnership
Surgery
service surgical device Robotics

This option This option

This move Partner with
focuses on offers potential
could open up other firms to
defending the future growth
new revenue jointly
existing but requires
streams and develop
market share significant
reduce advanced
but might not investment &
dependency versions of
be sufficient carries
on declining the devices.
against larger technological &
markets.
competitors. market risks.
P&L Statement 6/9

Income Statement
for RoboTech U.S.
(U.S. $000)

Income Statement -
RoboTech Corporate
(U.S. $000)
 Actions in 2017 7/9

01 02 03 04 05

Conduct a Prioritize short- Explore Communicating Implementing Cost

comprehensive term stability: partnerships or with Stakeholders: Controls:
strategic analysis: Secure existing collaborations: Maintain Identify and
Assess internal market share Seek partners for transparent eliminate
resources, through targeted R&D, distribution, communication unnecessary
competitor sales and service or technology with investors, expenses while
landscape, market expansion while sharing to employees, and optimizing resource
trends, and managing costs mitigate risks other stakeholders allocation.
potential risks and effectively. and leverage to manage
rewards of each external expectations and
option. expertise. build trust.
Opportunities
Market share Robotech
can keep 50% of the
market share and be
the market leader till
some joint venture
develops and sells
advanced medical
devices.
Opportunities:
Growing demand for
robotic surgery, the
potential for niche
markets within spinal
surgery, and
partnerships to access
resources and expertise.
8/9
Robotech's market The global market share
share is likely to face for orthopedic medical
pressure from larger devices is $34.5 Billion
competitors, but with spine devices
focusing on innovation, accounting for 20% of
strategic partnerships, the total
and cost-effective
Emerging Markets:
Challenges:
Untapped opportunities
Intense competition,
in developing regions
technological
with growing
advancements, and
healthcare
uncertain healthcare
infrastructure and rising
reimbursement policies.
middle-class population
 Robotech
Robot-Assisted Spinal Surgery

THANK
YOU